Ingevity Co. (NYSE:NGVT) Shares Acquired by Trillium Asset Management LLC

Trillium Asset Management LLC boosted its stake in Ingevity Co. (NYSE:NGVT - Free Report) by 51.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 114,925 shares of the company's stock after buying an additional 38,896 shares during the quarter. Trillium Asset Management LLC owned approximately 0.32% of Ingevity worth $4,684,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vestcor Inc acquired a new position in Ingevity during the third quarter worth $796,000. Geode Capital Management LLC raised its position in shares of Ingevity by 4.3% during the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company's stock valued at $31,817,000 after buying an additional 33,973 shares during the period. JPMorgan Chase & Co. lifted its holdings in Ingevity by 24.9% in the third quarter. JPMorgan Chase & Co. now owns 117,581 shares of the company's stock valued at $4,586,000 after acquiring an additional 23,460 shares during the last quarter. Hennion & Walsh Asset Management Inc. purchased a new position in Ingevity in the fourth quarter worth approximately $239,000. Finally, Proficio Capital Partners LLC acquired a new stake in Ingevity during the fourth quarter worth $863,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. BMO Capital Markets upgraded Ingevity from a "market perform" rating to an "outperform" rating and increased their price target for the stock from $62.00 to $65.00 in a report on Wednesday, February 26th. StockNews.com upgraded shares of Ingevity from a "hold" rating to a "buy" rating in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $55.17.

Remove Ads

Ingevity Stock Up 2.1 %

Shares of NYSE:NGVT traded up $0.88 during trading hours on Monday, reaching $43.26. The stock had a trading volume of 151,156 shares, compared to its average volume of 255,951. The company has a debt-to-equity ratio of 6.86, a quick ratio of 1.04 and a current ratio of 1.87. The firm's 50 day moving average is $45.28 and its 200-day moving average is $42.34. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of -3.65 and a beta of 1.53. Ingevity Co. has a 1 year low of $30.90 and a 1 year high of $56.30.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.29 by $0.66. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The firm had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Research analysts predict that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.